Adherence to anti-osteoporotic therapies: Role and determinants of "spot therapy"

Osteoporosis International

Volumn 24, Issue 8, 2013, Pages 2319-2323

  Tafaro, L ^a   Nati, G ^b   Leoni, E ^b   Baldini, R ^c   Cattaruzza, M S ^d   Mei, M ^b   Falaschi, P ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b FIMMG   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

^d SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Adherence; Compliance; Osteoporosis; Persistence; Spot therapy

Indexed keywords

ALENDRONIC ACID; CALCIUM; CLODRONIC ACID; IBANDRONIC ACID; PARATHYROID HORMONE; RALOXIFENE; RISEDRONIC ACID; STRONTIUM RANELATE; VITAMIN D;

ADULT; ARTICLE; CHRONIC DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DYSPEPSIA; FEMALE; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL SYMPTOM; GENERAL PRACTITIONER; HUMAN; ITALY; MALE; MEDICAL PRACTICE; MEDICAL RECORD; OSTEOPOROSIS; PATIENT COMPLIANCE; PRESCRIPTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADMINISTRATION, ORAL; AGED; ATTITUDE TO HEALTH; BONE DENSITY CONSERVATION AGENTS; CALCIUM; DATABASES, FACTUAL; DRUG ADMINISTRATION SCHEDULE; FAMILY PRACTICE; FEMALE; HUMANS; INJECTIONS, INTRAMUSCULAR; ITALY; MALE; MEDICATION ADHERENCE; MIDDLE AGED; OSTEOPOROSIS; OSTEOPOROSIS, POSTMENOPAUSAL; PHYSICIAN-PATIENT RELATIONS; VITAMIN D;

EID: 84880260504     PISSN: 0937941X     EISSN: 14332965     Source Type: Journal    
DOI: 10.1007/s00198-013-2283-z     Document Type: Article

References (21)

1. Kanis JA, Cooper C, Hiligsmann M, Rabenda V, Reginster J-Y, Rizzoli R (2011) Partial adherence: a new perspective on health economic assessment in osteoporosis. Osteoporos Int 22:2565-2573
2. Mc Combs JS, Thiebaud P, McLaughlin-Miley C, Shi J (2004) Compliance with drug therapies for the treatment and prevention of osteoporosis. Maturitas 48(3):271-287
3. Cramer JA, Amonkar MM, Hebborn A, Altman R (2005) Compliance and persistence with bisphosphonate dosing regimens among women with postmenopausal osteoporosis. Curr Med Res Opin 21(19):1453-1460
4. Penning-van Beest FJA, Erkens JA, Olson M, Herings RMC (2008) Loss of treatment benefit due to low compliance with bisphosphonate therapy. Osteoporos Int 19:511-517
5. Zambon A, Baio G, Merlino L, Mazzaglia G, Corrao G (2008) Dicontinuity and failures of therapy with bisphosphonates: joint assessment of predictors with multi-state models. Pharmacoepidem Dr S 17:260-269
6. Gallagher A, Rietbrock S, Olson M, Van Staa TP (2008) Fracture outcomes related to persistence and compliance with oral bisphosphonates. J Bone Miner Res 23:1569-1575
7. Siris ES, Harris ST, Rosen CJ, Barr CE, Abbot T (2006) Adherence to bisphosphonate therapy and fracture rates in osteoporotic women: relationship to vertebral and nonvertebral fractures from 2 US claims databases. Mayo Clin Proc 81(8):1013-1022
8. Seeman E, Compston J, Adachi J, Brandi ML, Cooper C, Cramer JA (2007) Non-compliance: the Achilles' heel of anti-fracture efficacy. Osteoporos Int 18:711-719
9. Sabaté E (ed) (2003) Adherence to long-term therapies: evidence for action. World Health Organization, Geneva
10. DiMatteo MR (2004) Variations in patients' adherence to medical recommendations: a quantitative review of 50 years of research. Med Care 42:200-209
11. Weycker D, Macarios D, Edelsberg J, Oster G (2006) Compliance with drug therapy for postmenopausal osteoporosis. Osteoporos Int 17:1645-1652
12. Rossini M, Bianchi G, Di Munno O, Giannini S, Adami S (2006) Determinants of adherence to osteoporosis treatment in clinical practice. Osteoporos Int 17(6):914-921
13. Rietbrock S, Olson M, vanStaa TP (2009) The potential effects on fracture outcomes of improvements in persistence and compliance with bisphosphonates. Q J Med 102:35-42
14. Segal E, Shalom S (2009) Two years adherence to anti-osteoporotic medications in postmenopausal Israeli women. Arch Gerontol Geriatr 49(3):360-363
15. Rossini M, Viapiana O, Gatti D, James G, Girardello S, Adami S (2005) The long term correction of vitamin D deficiency: comparison between different treatments with vitamin D in clinical practice. Minerva Med Apr 96(2 Suppl 2):1-7
16. Segal E, Tamir A, Shalom S (2003) Compliance of osteoporotic patients with different treatment regimens. IMAJ 5:859-862
17. Penning-van Beest FJA, Goettsch WG, Erkens JA, Herinhs RMC (2006) Determinants of persistence with bisphosphonates: a study in women with postmenopausal osteoporosis. Clin Ther 28(2):236-242
18. Carr AJ, Thompson PW, Cooper C (2006) Factors associated with adherence and persistence to bisphosphonate therapy in osteoporosis: a cross-sectional survey. Osteoporos Int 17:1638-1644
19. Hall JA, Roter DL, Katz NR (1988) Meta-analysis of correlates of provider behavior in medical encounters. Med Care 26:657-675
20. Stewart MA (1996) Effective physician-patient communication and health outcomes: a review. CMAJ 152:1423-1433
21. Roter DL, Hall JA, Aoki Y (2002) Physician gender effects in medical communication: a meta-analytic review. JAMA 288(6):756-764